他莫昔芬用于治疗腹膜后纤维化。

Tamoxifen for retroperitoneal fibrosis.

作者信息

Frankart L, Lorge F, Donckier J

机构信息

Division of Internal Medicine and Endocrinology, University Hospital UCL of Mont-Godinne, Yvoir, Belgium.

出版信息

Postgrad Med J. 1997 Oct;73(864):653-4. doi: 10.1136/pgmj.73.864.653.

DOI:10.1136/pgmj.73.864.653

PMID:9497980

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2431468/

Abstract

Retroperitoneal fibrosis, either idiopathic or associated with aortic inflammatory aneurysm, is a chronic fibrotic disease that causes progressive obstruction of ureters and vessels around the lower abdominal aorta. Treatment is often difficult (surgery) or hazardous (steroids). We report a case of a woman with retroperitoneal fibrosis associated with aortic inflammatory aneurysm, who was successfully treated with oral tamoxifen.

摘要

腹膜后纤维化，无论是特发性的还是与主动脉炎性动脉瘤相关的，都是一种慢性纤维化疾病，可导致下腹主动脉周围的输尿管和血管逐渐阻塞。治疗通常困难（手术）或有风险（类固醇）。我们报告一例与主动脉炎性动脉瘤相关的腹膜后纤维化女性患者，该患者口服他莫昔芬成功治愈。